End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
42.15 CNY | -1.77% | -0.50% | -6.81% |
Jun. 05 | Hengrui Pharma Units Get China Nod for Clinical Trial of Tumor Drug | MT |
May. 30 | Hengrui Pharmaceuticals Gets Nod to Trial Vitiligo Drug | MT |
Sales 2024 * | 26.45B 3.65B | Sales 2025 * | 29.82B 4.11B | Capitalization | 268B 36.98B |
---|---|---|---|---|---|
Net income 2024 * | 5.61B 774M | Net income 2025 * | 6.53B 901M | EV / Sales 2024 * | 9.25 x |
Net cash position 2024 * | 23.48B 3.24B | Net cash position 2025 * | 27.71B 3.82B | EV / Sales 2025 * | 8.06 x |
P/E ratio 2024 * |
47.9
x | P/E ratio 2025 * |
41.1
x | Employees | 19,611 |
Yield 2024 * |
0.46% | Yield 2025 * |
0.53% | Free-Float | 51.22% |
1 day | -1.77% | ||
1 week | -0.50% | ||
Current month | -0.50% | ||
1 month | -10.76% | ||
3 months | +0.48% | ||
6 months | -5.87% | ||
Current year | -6.81% |
Managers | Title | Age | Since |
---|---|---|---|
Hong Bin Dai
CEO | Chief Executive Officer | 48 | 00-06-30 |
Jian Jun Liu
DFI | Director of Finance/CFO | 47 | 21-11-18 |
Yu Xu
CMP | Compliance Officer | 32 | 21-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jie Ping Sun
BRD | Director/Board Member | 54 | 97-12-31 |
Hong Bin Dai
CEO | Chief Executive Officer | 48 | 00-06-30 |
Piao Yang Sun
CHM | Chairman | 65 | 03-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.18% | 1 M€ | -18.21% | - | |
3.73% | 2 M€ | -14.14% | ||
1.74% | 1 M€ | -9.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 42.15 | -1.77% | 23,854,730 |
24-06-06 | 42.91 | -2.30% | 22,586,850 |
24-06-05 | 43.92 | +0.21% | 18,067,570 |
24-06-04 | 43.83 | +3.13% | 35,813,890 |
24-06-03 | 42.5 | +0.33% | 18,780,090 |
End-of-day quote Shanghai S.E., June 06, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.81% | 36.98B | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
+11.88% | 216B | |
-0.78% | 219B | |
+5.90% | 164B |
- Stock Market
- Equities
- 600276 Stock